Geneva, June 9 -- International Clinical Trials Registry received information related to the study (ACTRN12625000559415) titled 'A Study Evaluating the Safety and Efficacy of Oral LMN-0801 Capsules for Weight Loss' on June 2.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Primary Sponsor: Lumen Bioscience, Inc.
Condition:
Obesity
Obesity
Diet and Nutrition - Obesity
Intervention:
Three oral capsules (400 mg per capsule) containing LMN-0801 taken once per day (Group 1 and 2), twice per day (Group 4-6) and three times per day (Group 7-10) for 24 weeks.
Participants will be completing a daily questionnaire to record drug self-administration. Participants will also bring used and u...